-
1.THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES 审中-公开
标题翻译: 使用本垂体腺苷酸环化酶激活多肽(PACAP)和PACAP ANALOG作为支持治疗钙调磷酸酶抑制剂或抑制剂MTOR-配合物的公开(公告)号:EP2533795A2
公开(公告)日:2012-12-19
申请号:EP11740499.6
申请日:2011-02-07
CPC分类号: A61K38/2235 , A61K38/13 , A61K45/06 , A61K2300/00
-
2.USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH ANTICANCER AGENTS 审中-公开
标题翻译: 使用本垂体腺苷酸环化酶激活多肽(PACAP)和PACAP ANALOG IN支疗程组合用抗癌剂
-